In the next vote, the advisers recommended adding a language to the risk of taking to the vaccine information sheet, which is already required by law.
The concentration of the Committee on Covid-19 vaccines reflects Kennedy’s long suspicion. From the time of taking office in February, Kennedy canceled half a billion dollars in research on MRNA vaccines and separately completed a earnest contract with Moderna, one of the producers of the final vaccine, in order to work on the vaccine against pandemic flu.
During the Friday meeting, CDC scientists presented extensive data on the safety and effectiveness of Covid vaccines. They also explained in detail how the Agency follows Covid hospitalizations and found that the agency has a “rigorous and standardized process” in order to determine whether hospitalizations are classified as resulting from Covid-19.
During the discussion, part of the meeting members of the Committee made several unfounded claims. Robert Malone, former MRNA researcher who has Spread the disinformation of the vaccineHe asked if there was really proof of the disease protection against covid shots. “Are there any well -defined, characterized correlations of Covid protection, yes or no?” He demanded.
Cody Meissner, a pediatrician at Dartmouth College, replied that “a reasonable measurement of neutralizing or binding antibodies correlates with protection against symptomatic infection during the first few months” after vaccination.
At one point, Hilary Blackburn, a pharmacist in the committee, wondered if the Covid vaccine could be associated with the diagnosis of lung cancer, which took place two years after receiving the vaccine from churches. She said that she was aware of four other people in her petite hometown, who was diagnosed with the same type of cancer. “Is it related to the vaccine?” She asked.
In a busy exchange on potential congenital defects related to Covid vaccines, some ACIP members pressed the Pfizer manufacturer Eight congenital defects It happened in a group of pregnant women who received a vaccine against companies and two birth defects that took place in an unvaccinated group. Alejandra Gurtman, who manages vaccine clinical tests and development in Pfizer, replied that these indicators are comparable to the indicators of congenital irregularities observed in the general population.
Carol Hayes, a connector with American College of Nurse-Midwives, who was present during the meeting, explained that most of the birth defects arise in the first trimester of pregnancy, and in the mother’s examination they received a vaccine after 12 to 24 weeks of pregnancy.
At the Friday meeting, the committee also reversed the decision, which he made only the day before. On Thursday, advisers voted not to recommend the combined measles, pigs, roses and chicken vaccines (MMRV) to children under 4 years aged. However, he mysteriously voted for maintaining a federal vaccine program for children for children, which provides free vaccines for children and people without insurance. On Friday they voted that the program should not actually cover it.
On Friday, the advisers also voted 11 to one in favor of making a decision to delay the birth dose of vaccine against hepatitis B up to a month. The committee discussed this vaccine intensively on Thursday, although it is not clear why the committee was asked to change, because the vaccine against hepatitis B was handed over to newborns in the USA since 1991.
Infants get a vaccine before leaving the hospital, because the virus can be donated from an infected mother to a child during delivery. Heat inflammation B is a earnest liver infection that can lead to cirrhosis and cancer. The vaccine is very effective in preventing newborns infection.
Chari Cohen, the president of the Foundation of Wateritis B, tells Wired that there is no scientific justification for delaying the vaccine against hepatitis B up to a month after birth, and worries about the enhance in infections of hepatitis B, if the panel ultimately recommends delaying vaccination.
“We will probably see more children and young children who will be infected,” says Cohen. “From the point of view of public health infrastructure, we are afraid that the risk -based approach will not prevent infection of children born for infected mothers.”
Up to 16 percent of pregnant women with HBV is not tested for hepatitis B, so screening does not capture all infected mothers.
“We do not understand the motivation or justification of this debate,” says Cohen.